Men who take a prostate-disease drug are more at risk of diabetes   > 자유게시판

Men who take medication to reduce their symptoms of prostate disease may be more likely to develop type 2 diabetes, research suggests.

Patients with enlarged prostates who are prescribed drugs called 5-alpha-reductase inhibitors are around a third more at risk of the condition. 

They reduce the production of androgens, a hormone which help to boost urinary flow, a common problem among men with enlarged prostates. 

But these drugs - which include finasteride and dutasteride - may slow metabolism and reduce the body's insulin sensitivity, which can trigger type 2 diabetes. 

Finasteride made headlines in 2017 when Donald Trump's doctor Harold Bornstein revealed the President takes the controversial drug to combat baldness.




Prostate-disease sufferers who take a commonly-prescribed drug to help them urinate are a third more at risk of type 2 diabetes, research suggests (stock) 

The research was carried out by the University of Edinburgh and University College London. It was led by Professor Ruth Andrew, a personal chair of pharmaceutical endocrinology at Edinburgh.

'We found that commonly prescribed medications for prostate disease can increase risk of type 2 diabetes,' Professor Andrew said. 

More than three million prescriptions of finasteride are issued every year by the NHS in England - and many more are bought privately. 

In the US, about eight million a year take it for prostate issues and 1.2million for hair loss.   




RELATED ARTICLES

Previous

1

Next



Toddler born with a tongue 'TWICE the size it should be'... Families are set to sue New York City over mandatory measles... Dementia-stricken husband generic viagra online canadian pharmacy who does not speak holds his... Traffic-related air pollution is causing FOUR MILLION new...



Share this article

Share

32 shares


The 5-alpha-reductase inhibitors are often prescribed to treat benign prostatic hyperplasia (BPH), the medical term for an enlarged prostate.

This becomes more common with age, with an estimated prevalence of between eight and 60 per cent in men aged 90. 

To determine the health effects of the drug, the researchers analysed the health records of 55,275 men in the UK who had been prescribed 5-alpha-reductase inhibitors for their BPH over 11 years.  

Results - published in the British Medical Journal - revealed the drugs raise a man's risk of developing type 2 diabetes by around one-third.